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Abstract
An Australian family was identiﬁed through a Public Health fol-
low up on a Shiga-toxigenic Escherichia coli (STEC) positive
bloody diarrhoea case, with three of the four family members
experiencing either symptomatic or asymptomatic STEC shed-
ding. Bacterial isolates were submitted to stx sequence sub-typ-
ing, multi-locus variable number tandem repeat analysis (MLVA),
multi-locus sequence typing (MLST) and binary typing. The analy-
sis revealed that there were multiple strains of STEC being shed
by the family members, with similar virulence gene proﬁles and
the same serogroup but differing in their MLVA and MLST pro-
ﬁles. This study illustrates the potentially complicated nature of
non-O157 STEC infections and the importance of molecular epi-
demiology in understanding disease clusters.
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Shiga-toxigenic Escherichia coli (STEC) can cause a broad
spectrum of clinical symptoms in humans, extending from
haemolytic uraemic syndrome through to mild non-bloody
diarrhoea or even asymptomatic carriage. Transmission of
STEC in humans is commonly associated with consumption
of contaminated food or water, or contact with positive ani-
mal faeces. Person-to-person transmission can occur among
household members and in childcare and residential care
facilities [1–3]. STEC can be shed for prolonged periods
from both previously symptomatic and asymptomatic individ-
uals, presenting a transmission risk long after the disease
symptoms have resolved [4,5].
Cases of STEC infection containing multiple STEC sero-
types or numerous E. coli types have been reported previ-
ously [5,6]. This study describes a household cluster of
STEC cases with symptomatic and asymptomatic shedding of
multiple STEC strains and an enteropathogenic E. coli strain.
Faeces from an adult male reporting bloody diarrhoea was
cultured on MacConkey agar after a broth enrichment step.
A sweep of the plate was screened with a multiplex PCR
targeting stx1, stx2, ehxA, eaeA and saa. Individual colonies
were tested using the same PCR, identifying a rough strain
with the gene proﬁle stx1, stx2 and ehxA [7].
The man, herein referred to as the father, had mentioned
recently consuming raw beef in his Public Health review; no
other signiﬁcant risk factors were identiﬁed. As part of the
Public Health Investigation, the other household mem-
bers—his wife (the mother) and two sons, all of whom
reported as asymptomatic, provided faeces samples for
screening. The mother and youngest son also had stx1+,
stx2+ and ehxA+ strains isolated from their faeces. The eldest
son did not have any STEC-positive faeces throughout this
investigation.
Queensland Health Guidelines require individuals with
positive STEC isolation to be excluded from duties involving
childcare or food preparation. The mother’s occupation was
a food handler, so her positive STEC isolation, despite her
asymptomatic state, required her to be excluded from any
duties that involved food preparation. The son who was
positive for STEC was of school age and did not attend
childcare so exclusion was not necessary. The father’s symp-
toms resolved in the time between his ﬁrst and second sam-
pling dates; however, the family continued to provide stool
samples to monitor STEC shedding. The mother was
required to achieve clearance, deﬁned as two negative stool
samples 48 h apart, before she could return to normal duties
at her job.
Table 1 outlines a selection of the faeces samples
screened for STEC target genes over a period of 4 months.
Two different gene proﬁles were identiﬁed in isolates from
the father, eaeA+ or stx1+, stx2+ and ehxA+, whereas only the
latter gene proﬁle was detected in isolates from the mother
and the younger son. All serogrouped isolates containing the
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gene proﬁle of stx1, stx2 and ehxA were determined to be
rough, O128:H- or O128:H2, whereas the eaeA+ isolate was
identiﬁed as O106:H34. O128 with this gene proﬁle is not
considered to be a seropathotype associated with severe dis-
ease; likewise eae-negative strains are typically less likely to
be implicated in serious clinical complications [8].
Multi-locus variable number tandem repeat analysis
(MLVA) proﬁles were produced for strains isolated from
each of the positive family members, as previously described
[9]. Of the father’s O128 isolates, there were two different
MLVA numbers, of which one was a different MLVA proﬁle
to the isolates from the mother and the youngest son,
despite the identical gene proﬁles and serogroup (Table 1).
The isolates were further characterized by multi-locus
sequence typing (MLST), where the father’s O128 isolates,
with the unique MLVA number, were identiﬁed as ST522, a
novel sequence type, and the other stx isolates from the
father and the mother and youngest son were ST130 [10].
ST130 and ST522 differ at ﬁve of the eight loci, indicating
that the strains are unlikely have recently diverged. The
eaeA+ isolate from the father was determined to be ST521,
also a novel sequence type.
The stx genes from positive isolates were submitted to stx
subtyping by PCR [11,12]. All stx2+ isolates from the three
family members were stx2b. This subtype is considered to
be a less potent toxin type and is rarely linked to haemolytic
uraemic syndrome [13]. The stx1+ isolates with the same
MLVA/MLST numbers from the father, mother and youngest
son were stx1c subtype, whereas the unique isolates from
the father were the stx1a subtype. Stx1c containing STEC
have been reported to be more likely to be shed asymptom-
atically and can be associated with eaeA– strains [14,15].
The stx1/2+ strains and the eae+ isolate were examined by
a PCR binary typing system (P-BIT) (Fig. 1) [16]. Three dif-
ferent P-BIT proﬁles were produced. The eae+ isolate also
ampliﬁed eaf and bfp gene products, a gene proﬁle indicative
of a typical enteropathogenic E. coli [17,18].
The mother achieved clearance by testing negative for
STEC in her faeces by both PCR and ELISA (Premier EHEC,
Meridian, Diagnostics Inc., Cincinnati, OH, USA) 4 weeks
after she was ﬁrst found to be carrying stx+ E. coli, allowing
her to return to work as a food handler. The father and youn-
gest son continued to test positive for STEC, both receiving
clearance 4 months after their ﬁrst positive faeces sample was
collected. Although prolonged asymptomatic carriage has
been best characterized in children, it has also been noted in
adults; a German study identiﬁed healthy adults shedding non-
O157 STEC strains for more than 10 months [19].
TABLE 1. Serogrouping, initial virulence genes detected and molecular typing results for Shiga-toxigenic Escherichia coli
(STEC) isolates from symptomatic and asymptomatic family members
Strain Patient Day collecteda Serogroup Genes present Stx subtype MLVA proﬁle MLST
SS11M1352 Fatherb 0 Rough stx1, stx2, ehxA Stx1a, Stx2b 7-3-0-8-0-5-1 ST522
SS11M1547 Mother 11 O128:H- stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M1633 Father 14 Rough stx1, stx2, ehxA Stx1a, Stx2b 7-3-0-8-0-5-1 ST522
SS11M1800 Youngest son 19 O128:H2 stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M1907 Mother 28 ND stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M2282 Mother 39 ND stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M2642 Youngest son 56 ND stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M3037 Father 70 O106:H34 eaeA ND 4-0-0-13-3-3-1 ST521
SS11M3038 Father 72 O128:H2 stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M3465 Father 91 O128:H- stx1, stx2, ehxA Stx1a, Stx2b 7-3-0-8-0-5-1 ST522
SS11M3601 Youngest son 99 O128 stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
SS11M3961 Youngest son 119 O128 stx1, stx2, ehxA Stx1c, Stx2b 6-3-0-8-3-8-1 ST130
aDays counted from the day the ﬁrst positive STEC stool sample was collected from the symptomatic father.
bSymptomatic when faeces sample was collected.























































































FIG. 1. Cluster dendrogram showing the
three binary gene proﬁles detected for the
Shiga-toxigenic Escherichia coli strains isolated
from family members and outlined in Table 1.
Dendrogram was produced using simple
matching coefﬁcient and Ward’s clustering in
BIONUMERICS v6.5 (Applied Maths, Sint-Martens-
Latem, Belgium).
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This report highlights the usefulness of performing molec-
ular epidemiological analysis on isolates belonging to house-
hold clusters. In this study, it was determined that the
symptomatic family member was carrying multiple STEC
strains, including a unique strain that, although having the
same serotype and gene proﬁle as the asymptomatic family
members’ strains, had a different MLVA proﬁle, MLST num-
ber and stx1 subtype. It is likely that the shedding of multiple
strains would have gone undetected without the use of
molecular typing. It is unknown which of the two strains was
responsible for causing the pathogenesis in the symptomatic
family member because both carried the necessary virulence
genes to cause symptoms.
It is known that STEC strains can undergo variation in vir-
ulence gene proﬁles over the course of a human infection
and that the genes for Shiga toxin and other virulence fac-
tors can be shared between E. coli strains [20]. Hence, it is
possible that transfer of mobile genetic elements between
bacterial strains in the family members has resulted in two
strains with the same serotype and stx1+, stx2+ and ehxA+
gene proﬁle but with different evolutionary histories accord-
ing to the MLVA and MLST types.
In conclusion, this case indicates how a seemingly simple
family cluster of STEC infection and carriage can reveal mul-
tiple E. coli strains with pathogenic potential, raising questions
over which strain is responsible for the disease reported.
This report illustrates the importance of molecular epidemi-
ological typing of non-O157 STEC clusters in enhancing
understanding into infections, asymptomatic carriage and
shedding of these strains.
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